Vivostat A/S

Vivostat A/S is a Danish medtech company that specializes in advanced surgical solutions through its proprietary Vivostat® System. This fully automated blood processing technology allows for the on-site preparation and application of autologous fibrin and platelet-enriched fibrin sealants derived from the patient’s own blood. The system enhances surgical procedures by utilizing natural biological materials, which improves healing and reduces risks such as rejection and infection. The Vivostat® System is primarily used in post-surgical procedures to promote wound healing and tissue repair. It has been employed in over 200,000 surgical procedures worldwide, with documented zero rejection and infection rates. Vivostat operates in six European countries and has a growing presence in Africa, Asia, and South America. The company has been profitable for the last three years, generating approximately €3.6 million in annual revenue with a gross profit margin of about 60%. Vivostat is recognized for its innovative approach to personalized healing solutions in the field of autologous fibrin sealant technology.

• Employees 10
• Founded 2000